Step 1
Draft
Step 2
Unite with Fellow Investors
Step 3
Choose the Best Attorney
Step 4
Provide Documents
Step 5
Follow Case Progress
Step 6
Get Payout
WGS.US
id: 1740
CM Life Sciences now GeneDx Holdings ($WGS) $21M Investor Settlement
Late claims are being considered for compensation, subject to approval.
$21,000,000
Cash SettlementDelaware court of Chancery
Court2024-0137-LWW
Case number07/19/2021
Class period Start07/22/2021
Class period End12/12/2024
Claim deadlineCM Life Sciences which later became Sema4 and now operates as GeneDx Holdings, $WGS, has agreed to a $21 million settlement to resolve claims that shareholders were misled in connection with the company’s 2021 de-SPAC merger and denied a fully informed choice about redeeming their shares.
Case Type
US Securities Class Action
Case Status
Accepting Late Claims
Alleged Offence
Misleading Statements,
Failure to Disclose,
Breach of Fiduciary duty
Suspected Party
Directors,
Management
Security Type
Stocks
Trade Direction
Long
Payout per Share
0.08
Plaintiffs
Dean William Drulias
Attorneys
Bernstein Litowitz Berger & Grossmann LLP
Defendants
Eli Casdin ; Keith Crandell ; Samarth Kulkarni ; John Maraganore ; Keith Meister ; Eli Casdin
Court hearing date
12/02/2024
Objection deadline
11/18/2024
Trades matching type
FIFO
Frequently Asked Questions
Who is eligible for this settlement?
Do I have to sell securities to be eligible?
How long does the payout process take?
How to get your payout?
What is 11th.com?
Trusted by industry leaders
Endorsed by top professionals who trust our innovative solutions to drive impactful results.